has been refreshed! Take a tour.
IAC Express 2008
Issue number 726: April 22, 2008
Contents of this Issue
Select a title to jump to the article.
  1. Latest U.S. hepatitis B birth dose rate is less than 50%. How to increase it? IAC Express readers may hold the answers.
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
Issue 726: April 22, 2008
1.  Latest U.S. hepatitis B birth dose rate is less than 50%. How to increase it? IAC Express readers may hold the answers.

Many of you are intimately involved in implementing CDC's hepatitis B (hepB) birth dose recommendations. You write orders, create standing orders, develop hospital policies, administer vaccines, document vaccines given in a hospital or practice, order lab tests, provide care to newborns and postpartum women, and make sure written orders are carried out. You are the key players in the complex decision-making process that results in a newborn receiving--or not receiving--hepatitis B vaccine before hospital discharge. You are best positioned, therefore, to shed light on how it is that the U.S. birth dose rate is so low and how it might be increased. For that reason, we have prepared an online survey aimed at gathering your views and experiences with the hepB birth dose. (If you have already filled out this survey after reading about it in Needle Tips, please do not fill it out again.) It is located at

Our goal is to provide the immunization community with an assessment of the following: how aware you and your colleagues are about CDC's most recent (December 2005) hepB birth dose recommendations, obstacles you have encountered in implementing them, any reasons you have for not implementing them, and actions taken in your work setting aimed at implementing or not implementing them. The survey is completely anonymous.

I am hopeful that your input to this survey will help better define factors that have enabled successful implementation of the 2005 hepB birth dose recommendations and factors that present obstacles to ensuring that all newborns receive this life-protecting vaccine.

Please consider taking a few minutes to fill out the online survey at

As always, thank you so much for all you do in pursuit of widespread and effective immunization.


Deborah L. Wexler, MD
Executive Director

Back to top

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .